StudyFinder



Clear

Search Results

Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.

1 Study Matches

A Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE) With Inadequate Response to Standard of Care (SOC) Therapy

This study is for patients with active Systemic Lupus Erythematosus(SLE) to test the effect and safety of different doses of the experimental drug AMG 570. To see if AMG 570 is a treatment option for SLE patients who are not responding to current standard of care.

Nancy Olsen
Jamie Carter - at jcarter3@pennstatehehalth.psu.edu or 717-531-0003, ext=283833
 

All
18 year(s) or older
This study is NOT accepting healthy volunteers
NCT04058028
STUDY00014615
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Diagnosis of SLE
Exclusion Criteria:
Active infection
Pregnant or breastfeeding
Arthritis & Rheumatic Diseases
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 1 location

Study Locations

Hide all locations
Location Contacts
Hershey, PA ,